메뉴 건너뛰기




Volumn 83, Issue 10, 2011, Pages 1696-1703

Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men

Author keywords

Antiretroviral therapy; Famciclovir; HHV 8; HIV; Valacyclovir

Indexed keywords

FAMCICLOVIR; PLACEBO; VALACICLOVIR;

EID: 80051577902     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.22194     Document Type: Article
Times cited : (22)

References (39)
  • 1
    • 0034611717 scopus 로고    scopus 로고
    • Kaposi's sarcoma
    • Antman K, Chang Y. 2000. Kaposi's sarcoma. N Engl J Med 342: 1027-1038.
    • (2000) N Engl J Med , vol.342 , pp. 1027-1038
    • Antman, K.1    Chang, Y.2
  • 3
    • 0036843921 scopus 로고    scopus 로고
    • Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: Frequency and clinical significance
    • Broccolo F, Bossolasco S, Careddu AM, Tambussi G, Lazzarin A, Cinque P. 2002. Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: Frequency and clinical significance. Clin Diagn Lab Immunol 9: 1222-1228.
    • (2002) Clin Diagn Lab Immunol , vol.9 , pp. 1222-1228
    • Broccolo, F.1    Bossolasco, S.2    Careddu, A.M.3    Tambussi, G.4    Lazzarin, A.5    Cinque, P.6
  • 6
    • 33748076772 scopus 로고    scopus 로고
    • Defining a role for antiviral drugs in the treatment of persons with HHV-8 infection
    • Casper C. 2006. Defining a role for antiviral drugs in the treatment of persons with HHV-8 infection. Herpes 13: 42-47.
    • (2006) Herpes , vol.13 , pp. 42-47
    • Casper, C.1
  • 7
    • 34547632214 scopus 로고    scopus 로고
    • The use of antiviral drugs in the prevention and treatment of Kaposi sarcoma, multicentric Castleman disease and primary effusion lymphoma
    • Casper C, Wald A. 2007. The use of antiviral drugs in the prevention and treatment of Kaposi sarcoma, multicentric Castleman disease and primary effusion lymphoma. Curr Top Microbiol Immunol 312: 289-307.
    • (2007) Curr Top Microbiol Immunol , vol.312 , pp. 289-307
    • Casper, C.1    Wald, A.2
  • 8
    • 0036791250 scopus 로고    scopus 로고
    • Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection
    • Casper C, Krantz E, Taylor H, Dalessio J, Carrell D, Wald A, Corey L, Ashley R. 2002a. Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection. J Clin Microbiol 40: 3822-3825.
    • (2002) J Clin Microbiol , vol.40 , pp. 3822-3825
    • Casper, C.1    Krantz, E.2    Taylor, H.3    Dalessio, J.4    Carrell, D.5    Wald, A.6    Corey, L.7    Ashley, R.8
  • 9
    • 0036534816 scopus 로고    scopus 로고
    • Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men
    • Casper C, Wald A, Pauk J, Tabet SR, Corey L, Celum CL. 2002b. Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men. J Infect Dis 185: 990-993.
    • (2002) J Infect Dis , vol.185 , pp. 990-993
    • Casper, C.1    Wald, A.2    Pauk, J.3    Tabet, S.R.4    Corey, L.5    Celum, C.L.6
  • 11
    • 33745130397 scopus 로고    scopus 로고
    • HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: Baseline data from the EXPLORE Study
    • Casper C, Carrell D, Miller KG, Judson FD, Meier AS, Pauk JS, Morrow RA, Corey L, Wald A, Celum C. 2006. HIV serodiscordant sex partners and the prevalence of human herpesvirus 8 infection among HIV negative men who have sex with men: Baseline data from the EXPLORE Study. Sex Transm Infect 82: 229-235.
    • (2006) Sex Transm Infect , vol.82 , pp. 229-235
    • Casper, C.1    Carrell, D.2    Miller, K.G.3    Judson, F.D.4    Meier, A.S.5    Pauk, J.S.6    Morrow, R.A.7    Corey, L.8    Wald, A.9    Celum, C.10
  • 12
    • 46349104673 scopus 로고    scopus 로고
    • Valganciclovir for suppression of human herpesvirus-8 replication: A randomized, double-blind, placebo-controlled, crossover trial
    • Casper C, Krantz EM, Corey L, Kuntz SR, Wang J, Selke S, Hamilton S, Huang ML, Wald A. 2008. Valganciclovir for suppression of human herpesvirus-8 replication: A randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis 198: 23-30.
    • (2008) J Infect Dis , vol.198 , pp. 23-30
    • Casper, C.1    Krantz, E.M.2    Corey, L.3    Kuntz, S.R.4    Wang, J.5    Selke, S.6    Hamilton, S.7    Huang, M.L.8    Wald, A.9
  • 13
    • 0034614893 scopus 로고    scopus 로고
    • Viral G protein-coupled receptor and Kaposi's sarcoma: A model of paracrine neoplasia?
    • Cesarman E, Mesri EA, Gershengorn MC. 2000. Viral G protein-coupled receptor and Kaposi's sarcoma: A model of paracrine neoplasia? J Exp Med 191: 417-422.
    • (2000) J Exp Med , vol.191 , pp. 417-422
    • Cesarman, E.1    Mesri, E.A.2    Gershengorn, M.C.3
  • 15
    • 0037151374 scopus 로고    scopus 로고
    • Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998
    • Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. 2002. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 94: 1204-1210.
    • (2002) J Natl Cancer Inst , vol.94 , pp. 1204-1210
    • Eltom, M.A.1    Jemal, A.2    Mbulaiteye, S.M.3    Devesa, S.S.4    Biggar, R.J.5
  • 16
    • 0042231990 scopus 로고    scopus 로고
    • Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma
    • Engels EA, Biggar RJ, Marshall VA, Walters MA, Gamache CJ, Whitby D, Goedert JJ. 2003. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS 17: 1847-1851.
    • (2003) AIDS , vol.17 , pp. 1847-1851
    • Engels, E.A.1    Biggar, R.J.2    Marshall, V.A.3    Walters, M.A.4    Gamache, C.J.5    Whitby, D.6    Goedert, J.J.7
  • 17
    • 2342649513 scopus 로고    scopus 로고
    • Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay
    • Friedrichs C, Neyts J, Gaspar G, De Clercq E, Wutzler P. 2004. Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay. Antiviral Res 62: 121-123.
    • (2004) Antiviral Res , vol.62 , pp. 121-123
    • Friedrichs, C.1    Neyts, J.2    Gaspar, G.3    De Clercq, E.4    Wutzler, P.5
  • 18
    • 31744433895 scopus 로고    scopus 로고
    • Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients
    • Funch DP, Walker AM, Schneider G, Ziyadeh NJ, Pescovitz MD. 2005. Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients. Am J Transplant 5: 2894-2900.
    • (2005) Am J Transplant , vol.5 , pp. 2894-2900
    • Funch, D.P.1    Walker, A.M.2    Schneider, G.3    Ziyadeh, N.J.4    Pescovitz, M.D.5
  • 22
    • 0030980240 scopus 로고    scopus 로고
    • Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy
    • Kedes DH, Ganem D. 1997. Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest 99: 2082-2086.
    • (1997) J Clin Invest , vol.99 , pp. 2082-2086
    • Kedes, D.H.1    Ganem, D.2
  • 26
    • 68249102795 scopus 로고    scopus 로고
    • Use of the designation "shedder" in mucosal detection of herpes simplex virus DNA involving repeated sampling
    • Magaret AS, Johnston C, Wald A. 2009. Use of the designation "shedder" in mucosal detection of herpes simplex virus DNA involving repeated sampling. Sex Transm Infect 85: 270-275.
    • (2009) Sex Transm Infect , vol.85 , pp. 270-275
    • Magaret, A.S.1    Johnston, C.2    Wald, A.3
  • 27
    • 34748814250 scopus 로고    scopus 로고
    • HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load
    • Maurer T, Ponte M, Leslie K. 2007. HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load. N Engl J Med 357: 1352-1353.
    • (2007) N Engl J Med , vol.357 , pp. 1352-1353
    • Maurer, T.1    Ponte, M.2    Leslie, K.3
  • 28
    • 0030767409 scopus 로고    scopus 로고
    • In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus
    • Medveczky MM, Horvath E, Lund T, Medveczky PG. 1997. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. AIDS 11: 1327-1332.
    • (1997) AIDS , vol.11 , pp. 1327-1332
    • Medveczky, M.M.1    Horvath, E.2    Lund, T.3    Medveczky, P.G.4
  • 29
    • 0030782743 scopus 로고    scopus 로고
    • Antiviral drug susceptibility of human herpesvirus 8
    • Neyts J, De Clercq E. 1997. Antiviral drug susceptibility of human herpesvirus 8. Antimicrob Agents Chemother 41: 2754-2756.
    • (1997) Antimicrob Agents Chemother , vol.41 , pp. 2754-2756
    • Neyts, J.1    De Clercq, E.2
  • 30
    • 43249098782 scopus 로고    scopus 로고
    • Persistent Kaposi sarcoma in the era of HAART: Characterizing the predictors of clinical response
    • Nguyen HQ, Magaret AS, Van Rompaey SE, Kitahata MM, Wald A, Casper C. 2008. Persistent Kaposi sarcoma in the era of HAART: Characterizing the predictors of clinical response. AIDS 22: 937-945.
    • (2008) AIDS , vol.22 , pp. 937-945
    • Nguyen, H.Q.1    Magaret, A.S.2    Van Rompaey, S.E.3    Kitahata, M.M.4    Wald, A.5    Casper, C.6
  • 31
    • 80051595925 scopus 로고    scopus 로고
    • KSHV LANA serological assay in the identification of immunocompetent asymptomatic KSHV infected individuals, and the development of improved methods for assaying neutralizing antibodies to KSHV. 10th International Workshop on Kaposi's Sarcoma Associated Herpesvirus (KSHV) and Rlated Agents. Portland, OR.
    • Oda-Ikoma M, Casper C, Johnston C, Selke S, Morrow R, Corey L, Vieira J. 2007. KSHV LANA serological assay in the identification of immunocompetent asymptomatic KSHV infected individuals, and the development of improved methods for assaying neutralizing antibodies to KSHV. 10th International Workshop on Kaposi's Sarcoma Associated Herpesvirus (KSHV) and Rlated Agents. Portland, OR.
    • (2007)
    • Oda-Ikoma, M.1    Casper, C.2    Johnston, C.3    Selke, S.4    Morrow, R.5    Corey, L.6    Vieira, J.7
  • 33
    • 0031984708 scopus 로고    scopus 로고
    • Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial
    • Schacker T, Hu HL, Koelle DM, Zeh J, Saltzman R, Boon R, Shaughnessy M, Barnum G, Corey L. 1998. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial. Ann Intern Med 128: 21-28.
    • (1998) Ann Intern Med , vol.128 , pp. 21-28
    • Schacker, T.1    Hu, H.L.2    Koelle, D.M.3    Zeh, J.4    Saltzman, R.5    Boon, R.6    Shaughnessy, M.7    Barnum, G.8    Corey, L.9
  • 34
    • 19944428400 scopus 로고    scopus 로고
    • Antiviral therapy for cirrhotic hepatitis C: Association with reduced hepatocellular carcinoma development and improved survival
    • for the Tokyo-Chiba Hepatitis Research Group.. -.
    • Shiratori Y, Ito Y, Yokosuka O, Imazeki F, Nakata R, Tanaka N, Arakawa Y, Hashimoto E, Hirota K, Yoshida H, Ohashi Y, Omata M, for the Tokyo-Chiba Hepatitis Research Group. 2005. Antiviral therapy for cirrhotic hepatitis C: Association with reduced hepatocellular carcinoma development and improved survival. Ann Intern Med 142: 105-114.
    • (2005) Ann Intern Med , vol.142 , pp. 105-114
    • Shiratori, Y.1    Ito, Y.2    Yokosuka, O.3    Imazeki, F.4    Nakata, R.5    Tanaka, N.6    Arakawa, Y.7    Hashimoto, E.8    Hirota, K.9    Yoshida, H.10    Ohashi, Y.11    Omata, M.12
  • 35
  • 37
  • 39
    • 38449119047 scopus 로고    scopus 로고
    • Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: A randomized, double-blind, placebo-controlled crossover trial
    • Zuckerman RA, Lucchetti A, Whittington WL, Sanchez J, Coombs RW, Zuniga R, Magaret AS, Wald A, Corey L, Celum C. 2007. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: A randomized, double-blind, placebo-controlled crossover trial. J Infect Dis 196: 1500-1508.
    • (2007) J Infect Dis , vol.196 , pp. 1500-1508
    • Zuckerman, R.A.1    Lucchetti, A.2    Whittington, W.L.3    Sanchez, J.4    Coombs, R.W.5    Zuniga, R.6    Magaret, A.S.7    Wald, A.8    Corey, L.9    Celum, C.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.